Thursday, April 12, 2012
Israeli woman wins top European science research award
by Meredith Mandell, Jweekly.com
She's young, smart and takes aim at life-threatening diseases.
Naama Geva-Zatorsky, 34, is among a growing group of Israeli female scientists who are gaining recognition for their contributions to scientific research.
The Weizmann Institute biologist was in Paris last month to accept the International UNESCO L'Oreal Prize for Women in Science. Dubbed "Europe's top young researcher" by the prize committee, she received a two-year, $40,000 fellowship for her postdoctoral work at Harvard University.
Serendipity and Science: 30 Minutes with Dr. Sharon Long
By Ellen Crocker | April 12, 2012 |
A series of graduate student conversations with leading women biologists, at the Women in Science Symposium at Cornell April 2-3.
Dr. Sharon Long, Steere-Pfizer Professor of Biological Science at Stanford UniversityDr. Sharon Long is a remarkable scientist. Known for her ground-breaking work on signaling between legumes and nitrogen-fixing bacteria, Dr. Long is a Professor at Stanford University, a member of the National Academy of Sciences and a MacArthur Fellow. Dr. Long was one of eight distinguished women scientists invited to speak at this month's Frontiers Symposium at Cornell University, celebrating excellence in the life sciences. During this event I sat down with Dr. Long to talk about her career path, how she approaches science, and, of course, to pick her brain for pearls of wisdom a graduate student such as myself could use.
Amy Bucha, a senior at the University of Delaware College of Engineering, was an exhibitor at the American Association of University Women's 13th annual Awards for Excellence in Science for Outstanding High School Junior Women in Delaware.
"The Wellcome Trust – the world's largest non-governmental funder of biomedical research* – is branching out into venture capital. The London-based organization announced today (20 March) that it would launch a £200 million business to invest directly in health-care and life-sciences companies. That's a small but noteworthy change of strategy for the charity, which hands out £600 million in research grants each year and has a £14 billion endowment."